Clinical Trial Sites
Basic Information
-
Institution Name
- Keimyung University Dongsan Hospital
-
Homepage(English)
- https://eng.dsmc.or.kr:49910/
-
Address
- 1035, Dalgubeol-daero, Dalseo-gu, Daegu, Korea
-
Type
- Tertiary General Hospital
-
Number of Beds
- 1104
-
Designation Of Specialized Rare Disease Institutes
- N
-
Designation Of Regional Cancer Center
- N
-
Specialized Fields And Key Strengths Of The Institution
-
Introduction Materials (Upload attachment)
Types of Medical Departments
Infectious Diseases
Endocrinology And Metabolism
Rheumatology
Gastroenterology
Cardiology
Nephrology
Allergy And Immunology
Hematology And Oncology
Pulmonology
Hepatobiliary And Pancreatic Surgery
Breast And Endocrine Surgery
Colon And Rectal Surgery
Gastrointestinal Surgery
Vascular And Transplant Surgery
Family Medicine
Anesthesiology And Pain Medicine
Radiation Oncology
Pathology
Urology
Obstetrics And Gynecology
Plastic Surgery
Pediatric Surgery
Pediatrics
Neurology
Neurosurgery
Ophthalmology
Radiology
Acute Care Surgery
Emergency Medicine
Otolaryngology
Rehabilitation Medicine
Psychiatry
Orthopedic Surgery
Occupational And Environmental Medicine
Laboratory Medicine
Dentistry
Dermatology
Nuclear Medicine
Chest Surgery (Thoracic And Cardiovascular Surgery)
-
Other
- 0
Certification Status
-
ISO 9001
- -
-
ISO 14155
- -
-
AAHRPP
- -
-
GCLP
- -
-
CAP
- -
-
ISO 13485
- -
- Other
- 0
Clinical Trial Count by Therapeutic Area
- Anticancer
- 18
- Cardiovascular
- 6
- Endocrine
- 6
- Infectious Diseases (e.g., Antibiotics)
- 0
- Central Nervous System (CNS)
- 3
- Gastrointestinal
- 8
- Respiratory
- 2
- Immunosuppressants
- 0
- Genitourinary
- 1
- Hematology
- 2
- Dermatology
- 0
- Musculoskeletal
- 2
- Psychiatry
- 0
- Other
- 5
- Total
- 53
Clinical Trial Count Based on MFDS Approval Status in 2024
Clinical Trial Count by Phase
- Phase 0
- 0
- Phase 1
- 4
- Phase 2
- 9
- Phase 3
- 35
- Phase 4
- 1
- Bioequivalence Study
- 0
- Investigator-Initiated Trial
- 4
- Investigator-Initiated Clinical Trials with Non-MFDS-Approved Drugs (IIT)
- 0
- Total
- 53
Clinical Trial Count Based on MFDS Approval Status in 2024
Clinical Trial Count by Country
- Domestic Only(Korea)
- 16
- Multinational
- 37
- Total
- 53
Clinical Trial Count Based on MFDS Approval Status in 2024
Institution Clinical Trial Center
-
Availability of Clinical Trial Center
- Y
-
Clinical Trial Center Website Address
- https://ctc.dsmc.or.kr:49850/
-
Clinical Trial Center Email
- sug8525@dsmc.or.kr
-
Number of Beds in Clinical Trial Center
- 0
-
Clinical Trial Center Phone Number
- 053-258-6653
IRB (Institutional Review Board)
-
IRB Homepage
- Y
-
IRB E-mail
- ys00125@dsmc.or.kr
-
IRB Phone Number
- 053-250-8021
-
Review Schedule and Frequency
- 1
-
Average IRB Approval Time (Full Board Review)(day)
- 0
-
Average IRB Approval Time (Expedited Review)(day)
- 0
-
Average Clinical Trial Contract Execution Time
- 0